Daptomycin Structural Formula (Image 01)
Dapzura Rt Injection, Powder, Lyophilized, For Solution
Product Images NDC 60977-145
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dapzura Rt (NDC 60977-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Daptomycin Representative Container Label 60977-145-01 (Image 02)
This is a pharmaceutical product information of Dapzura. It comes in a single-dose vial of 500mg and must be stored between 20°C to 25°C. The package insert has details on the recommended dosage, storage of reconstituted, and diluted product. It is manufactured by Baxter Healthcare Corporation, and it is only available for prescription. The lot number and expiration date are also provided.*
Daptomycin Representative Carton Label 60977-145-01 (Image 03 1 Of 2)
Image 04 2 Of 2
This is a description of Dapzura - a drug used for intravenous injection. Each vial contains 500 mg of daptomycin and needs to be reconstituted with either sterile water or bacteriostatic water. It contains no preservatives, and parental drug products need to be visually inspected for particulate matter before administration. More information on dosage and administration can be found in the enclosed package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
